Skip to main content
. 2023 Jul 21;13:1222716. doi: 10.3389/fonc.2023.1222716

Figure 3.

Figure 3

(A) Comparison of TPS(Tumor Positive Score) expression between postoperative MRD-positive patients and MRD-negative patients; (B) Comparison of CPS(Combined Positive Score ) expression between postoperative MRD-positive patients and MRD-negative patients; (C) Comparison of TMB expression between postoperative MRD-positive patients and MRD-negative patients.(TMB-L:Tumor Mutational Burden-Low;TMB-M:Tumor Mutational Burden-middle;TMB-H:Tumor Mutational Burden-High); (D) Comparison of HLA between postoperative MRD-positive patients and MRD-negative patients.(HLA-Hb : Human leukocyte antigen-;HLA-PH;HLA-HZ).